{{Rsnum
|rsid=6132333
|Gene=RALGAPA2
|Chromosome=20
|position=20653462
|Orientation=plus
|GMAF=0.08448
|Gene_s=RALGAPA2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 0.0 | 4.4 | 95.6
| HCB | 1.5 | 31.1 | 67.4
| JPT | 0.9 | 19.5 | 79.6
| YRI | 0.7 | 7.5 | 91.8
| ASW | 0.0 | 12.5 | 87.5
| CHB | 1.5 | 31.1 | 67.4
| CHD | 2.8 | 27.8 | 69.4
| GIH | 0.0 | 5.0 | 95.0
| LWK | 0.0 | 21.1 | 78.9
| MEX | 0.0 | 12.1 | 87.9
| MKK | 1.3 | 15.5 | 83.2
| TSI | 0.0 | 5.0 | 95.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23382691
  |Trait=IgG glycosylation
  |Title=Loci associated with N-glycosylation of human immunoglobulin G show pleiotropy with autoimmune diseases and haematological cancers.
  |RiskAllele=C
  |Pval=8E-6
  |OR=.49
  |ORtxt=[0.28-0.71] unit increase
  |OA=1
}}

{{on chip | Illumina Human 1M}}